Infection Control Market Size was valued at USD 43.7 Billion in 2023. The Global Infection Control industry is projected to grow from USD 44.5 Billion in 2024 to USD 49.0 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.60% during the forecast period (2024 - 2032).
The rising prevalence of hospital-acquired infections and growing awareness regarding cleanliness post-pandemic are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
June 2023: The FDA approved a new surgical mask manufactured to give better protection against airborne pathogens to healthcare workers. PLOS One published a study on how using this new hand hygiene product considerably decreased HAIs.
March 2023: APIC issued a new guideline on ultraviolet (UV) lighting for disinfection purposes in healthcare settings. A recent article in the journal Infection Control and Hospital Epidemiology has shown how profound the reduction of healthcare-associated infections would be if hydrogen peroxide vaporization was used as the disinfectant instead.
In the Asia Pacific region, Advanced Sterilization Products, which is owned by Fortive Company, introduced STERRAD VELOCITY in August 2021. To promote safe medical practices and reinforce ASP’s presence within this specific market segment, Sterrad Velocity offers another opportunity for sterilization validation through a Biological Indicator/Process Challenge Device.
Nanosonics introduced Nanosonics AuditPro in June 2021, an innovative digital platform for infection prevention. It integrates advanced technology into infection control processes of health facilities, thus ensuring improved efficiency and effectiveness.
For example, Steris announced its acquisition of Cantel Medical, a global provider of products preventing infection as well as offering services to dialysis dental endoscopy life sciences customers. Similarly, the company also launched its four-hour rapid readout biological indicator for vaporized hydrogen peroxide sterilization, which gives results in 4 hours and monitored steam sterilization loads. The product was launched to expand the company’s product portfolio.
Also, in November 2020, Applicon Biotechnology, a division of Getinge, introduced AppliFlex ST, a flexible single-use bioreactor that optimizes laboratory processes and cuts down on labor time. Besides, collaborative strategies are being established by companies to enhance infection control capabilities.
Millions of patients suffer injuries or deaths yearly due to unsafe and subpar medical care. The burden of harm from inadequate care is significantly increased by numerous medical procedures and risks related to health care. According to World Health Organization, up to 25% of patients experience complications due to unsafe surgical procedures. Every year, nearly 7 million surgical patients experience significant difficulties, and 1 million pass away during or right after surgery. In hospitals in high-income and low- and middle-income countries, healthcare-associated infections affect 7 and 10 out of every 100 patients. Moreover, according to the Centers for Disease Control (CDC), HAIs are thought to be responsible for 1.7 million infections and 99,000 deaths each year. Urinary tract infections make up about 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%). The growing rate of infections in hospitals has fueled the need for infection control products and boosted market growth.
The various countries' governments are also taking measures to prevent the spread of infection. They are conducting programs or investing to help hospitals control the spread of infections that can harm patients. For instance, in February 2009, President Obama signed Public Law 111-5 (ARRA), also known as the American Recovery and Reinvestment Act of 2009. The Recovery Act authorized USD 50 million to assist states in preventing and reducing infections related to healthcare. Many of these funds support the initiatives listed in the HHS Action Plan to Prevent Health Care-Associated Infections. The Recovery Act site also tracks the efforts made by the states to achieve the plan's objectives. Similarly, Cambridge Health Alliance implemented a 15-month safety improvement programme, sponsored by the Agency for Healthcare Research & Quality, to lower infections in the ICU at its Cambridge and Everett hospitals. Urinary tract infections and central line-associated bloodstream infections significantly decreased due to the effort, which also included assessing potential issues, increased staff education, using tried-and-true best practices, leadership buy-in, and more (CLABSI). Such initiatives are anticipated to positively impact the Infection Control market CAGR across the globe in the coming years.
Moreover, covid-19 pandemic has boosted market growth because hospitals, clinics, pharmaceuticals, and medical device firms now have higher demands for sterilization and disinfection. Additionally, the production of sanitizer products increased by 60% during the pandemic in the United States alone. This demonstrates the growth potential for infection control products in the upcoming years. The introduction of cutting-edge sterilizing solutions and a rise in the outsourcing of sterilization services are among the other factors driving the growth of the Infection Control market revenue.
The global Infection Control market segmentation, based on type, includes disinfection products, sterilization products and services, and others. The sterilization products and services segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2024-2032. The primary factors propelling the market growth are the growing need to reduce hospital-acquired infections and the extensive use of sterilization equipment in healthcare settings. Additionally, the market is expected to grow over the forecast period due to rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector.
March 2022: Datasea Inc. introduced Ultrasonic Sound Sterilization and Antivirus Equipment aimed at various application scenarios, and it intended to enter the US market with acoustic intelligence products.
May 2020: ATS ELGi introduced a new line of vehicle sterilization products. The Ozone Air Sterilizer uses ozone (a natural form of activated oxygen) to kill bacteria, viruses, molds, allergens, odors, and harmful pollutants like volatile organic compounds (VOCs), ensuring a clean and safe environment inside small passenger cars, sedans, SUVs, commercial vehicles, SCV/LCV/HCV driver cabins, and even ambulances.
Based on End Users, the global Infection Control market segmentation has been divided into hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others. The hospitals and clinics segment is anticipated to hold the largest market share and grow at a significant CAGR during the coming years. The significant market share is primarily due to the increased risk of contracting infections on hospital grounds through the transmission of respiratory or bloodborne pathogens. HAIs are one of the main problems, so strict control is needed. The need for highly effective control systems has prompted hospitals and public health organizations to adopt them. Additionally, there has been a rise in the use of infection control products due to the rising number of COVID-19 patients and strict regulations put in place by the various governments to combat infections. The life sciences industry is anticipated to grow with the fastest CAGR during the forecast period owing to increasing R&D activities for developing new medicines and vaccines.
Figure 1: Infection Control Market, by End Users, 2022 & 2032 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America Infection Control market accounted for USD 19.3 billion in 2022 and is expected to exhibit a noteworthy CAGR growth during the study period. A well-developed healthcare infrastructure, widespread use of infection control technologies, and the presence of major market players in the area are some significant drivers of market growth. In addition, recent product launches and government infection control initiatives contribute to the market's expansion.
Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: INFECTION CONTROL MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe Infection Control market accounts for the second-largest market share in 2022. Growing government attention to the healthcare industry, an increase in the prevalence of chronic diseases, the COVID-19 pandemic, government funding for the expansion of healthcare facilities, and favorable regulatory reforms are all contributing to the market's growth. Further, the Germany Infection Control market held the largest market share, and the UK Infection Control market was the fastest-growing market in the European region.
The Asia-Pacific Infection Control Market is anticipated to grow at the fastest CAGR from 2024 to 2032. An increase in outsourcing companies, a rise in healthcare spending, and an unprecedented region-wide transformation of healthcare infrastructure and standards are driving the market. One of the key factors influencing the expansion of the Asia Pacific region is the existence of numerous nonprofit and governmental organizations dedicated to raising infection control standards. Moreover, China Infection Control market held the largest market share, and the India Infection Control market was the fastest-growing market in the Asia-Pacific region.
Infection Control Key Market Players & Competitive Insights
Major market players are investing in new products, which is expected to help the Infection Control market grow in the coming years. Companies in the market are also taking various initiatives to expand their worldwide footprint, with key market developments such as new product launches, agreements, increased investments, and collaboration with other companies. Competitors in the Infection Control industry must offer low-cost products to maintain their position in the market.
Major players are adopting strategies such as collaborating with other manufacturers in the global Infection Control industry to expand their presence. Recently, the Infection Control industry has launched some new products to meet the rising demand. The Infection Control markets major player such as STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), and others are working to introduce new tiles and expanding the market demand by investing in R&D activities.
Advanced Sterilization Products Advanced Sterilization Products (ASP) provide infection prevention solutions for healthcare. The company offers cutting-edge medical sterilization and disinfection products, technologies, and workflows. In August 2021, Advanced Sterilization Products (ASP) announced that the STERRAD VELOCITY Biological Indicator (BI)/Process Challenge Device (PCD) would have a 15-minute time to result and be commercially available in the Asia Pacific region starting on August 25, 2021.
STERIS Life Sciences is a global leader in offering the industries of sterilization, cleaning, and infection control products. In September 2021, STERIS introduced the next generation of integrated Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems for clients seeking to reduce bioburden in GMP pharmaceutical, medical device, and research environments by up to 6-logs. The new VHP 100i and 1000i can run a decontamination cycle at predetermined intervals or in response to a button press. They are made to be integrated into a facility's building automation and HVAC systems. As a result, decontamination of rooms, isolators, filling lines, RABs, pass-through chambers, and other areas is made simple and frequent.
Key Companies in the Infection Control market include
Infection Control Industry Developments
January 2023: W&H, Windsor, introduced the Lexa Plus sterilizer, a pre-vacuum, Class B sterilizer that offers increased capacity, energy-saving fast cycles, automatic water filling, connectivity, and options for traceability.
September 2019: STERIS Corporation introduced Spor-Klenz Ready to Use Disinfectant Wipes for cleanroom disinfectant applications. The Spor-Klenz Ready to Use Disinfectant Wipes utilize a cutting-edge system that combines woven polyester wipes with a unique internal pouch containing the Spor-Klenz Ready to Use formula. In addition to providing a quick, easy, and reliable way to saturate the wipes, the internal pouch enables maximum chemical stability.
North America
Europe
Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 43.7 billion |
| Market Size 2024 | USD 44.5 billion |
| Market Size 2032 | USD 49.0 billion |
| Compound Annual Growth Rate (CAGR) | 5.60% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 - 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain) |
| Key Market Opportunities | Growing number of surgical procedures |
| Key Market Dynamics | Covid-19 pandemic Rising prevalence of HAIs Growing government initiatives |
Infection Control Market Highlights:
Frequently Asked Questions (FAQ) :
The global Infection Control market size was valued at USD 43.7 Billion in 2023.
The global market is projected to grow at a CAGR of 5.60% during the forecast period, 2024-2032.
North America had the largest share of the global market
The key players in the market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), and Others.
The sterilization products and services category dominated the market in 2023.
The hospitals and clinics had the largest share of the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
